This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
10-07/08 :: July/August 2010


nanotimes


Companies Facts


on ARM processors and covers a wide range of pro- cess nodes extending down to 20nm.


End of July, ARM Holdings plc announced its unau- dited financial results for the second quarter and half year ended June 30, 2010. Total dollar revenues in Q2 2010 were $150.3 million, up 42% on Q2 2009. Group order backlog at the end of Q2 2010 is up more than 20% sequentially. This is ARM’s highest ever backlog, driven partly by long-term strategic deals such as the multi-year architecture license signed with Microsoft and licenses signed with lead- customers for the Eagle processor. http://www.arm.com


for its fiscal 2010 third quarter ended June 30, 2010. For the quarter ended June 30, 2010, Arrowhead reported revenue of $134,000, compared with $2.6 million in the quarter ended June 30, 2009.


A


Net loss for the quarter ended June 30, 2010 was $0.4 million, or $0.01 per share based on 64.6 million weighted average shares outstanding. This compares with a net loss of $2.5 million, or $0.6 per share based on 43.4 million weighted average shares outstanding, for the quarter ended June 30, 2009. In addition to the change in revenue and operating ex- penses, a non-cash gain of $1.6 million was recorded as the change in value of a derivative liability. http://www.arrowheadresearch.com


rrowhead Research Corporation (NASDAQ:ARWR) announced financial results


B B


acterin International, Inc., a developer of revolutionary bone graft material, announced a


three year agreement to provide its biologic line of products, OsteoSponge® SC®


, OsteoSelect® , OsteoWrap® vast Broadlane® , BacFast®


medical practices. http://www.bacterin.com


uhler will be represented its new functional additive Oxylink™ to the Asian market at the


Chinacoat 2010 in Guangzhou, China, from Sep- tember 27 to 29, 2010. The innovative additive comprises a performance-optimized formulation of nanoparticles in water. Oxylink™ increases the cross-link density of waterborne resin systems which results in an enhanced overall performance including increased MEK rub resistance, blocking and humidi- ty resistance, as well as other resistance properties. In addition, Oxylink™ reduces the time to further processing of the coated substrates. The additive strengthens the film by direct chemical interaction of its tailor-made nanoparticles with the functional groups of the polymeric binder. As Oxylink™ doesn’t change the in-can stability of the formula it is parti- cularly interesting for 1-pack systems. http://www.buhlergroup.com/global/en/products/oxylink.htm


C


abot Microelectronics Corporation (NASDAQ: CCMP), the world‘s leading supplier of chemi-


cal mechanical planarization (CMP) polishing slurries and growing CMP pad supplier to the semiconductor industry, announced that on July 8, 2010, the validity of all Cabot Microelectronics‘ patents were upheld in the company‘s ongoing patent enforcement litigation in the United States District Court for the District of Arizona against DuPont Air Products NanoMateri-


, and OsteoLock®


, OsteoSponge to the


nationwide network of hospitals and


17


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83